hemangiol
pierre fabre medicament - propranolol clorhidrato - hemangioma - agentes beta bloqueantes - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
propranolol 40 mg tableta
hersil s.a. laboratorios industriales farmaceuticos - clorhidrato de propranolol; - tableta - por tableta - propranolol
propranolol clorhidrato solución inyectable 1 mg/ml
laboratorio biosano s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 10 mg
bph s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 10 mg
laboratorios andrÓmaco s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 10 mg
laboratorio chile s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 10 mg
laboratorio maver s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 10 mg
laboratorio pasteur s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 40 mg
laboratorios andrÓmaco s.a. - propranolol - sin formulas
propranolol clorhidrato comprimidos 40 mg
mintlab co. s.a. - propranolol - sin formulas